BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 27076443)

  • 1. Glucocorticoids and erythropoietin in chronic lung disease of prematurity: Proliferative potential in lung fibroblast and epithelial cells exposed to tracheal aspirates.
    Ohnishi S; Ichiba H; Saito M; Hamazaki T; Matsumura H; Shintaku H
    Pediatr Int; 2016 Nov; 58(11):1163-1170. PubMed ID: 27076443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mitogenic activity of tracheal effluents from premature infants with chronic lung disease.
    Saito M; Ichiba H; Yokoi T; Hirai C; Yamano T; Kusuda S
    Pediatr Res; 2004 Jun; 55(6):960-5. PubMed ID: 15028841
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thrombin contributes to bronchoalveolar lavage fluid mitogenicity in lung disease of the premature infant.
    Dik WA; Zimmermann LJ; Naber BA; Janssen DJ; van Kaam AH; Versnel MA
    Pediatr Pulmonol; 2003 Jan; 35(1):34-41. PubMed ID: 12461737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased numbers of macrophages in tracheal aspirates in premature infants with funisitis.
    Arai H; Matsuda T; Goto R; Takada G
    Pediatr Int; 2008 Apr; 50(2):184-8. PubMed ID: 18353056
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytological changes in endotracheal aspirates associated with chronic lung disease.
    Todd DA; Earl M; Lloyd J; Greenberg M; John E
    Early Hum Dev; 1998 Apr; 51(1):13-22. PubMed ID: 9570027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Protective effects of amygdalin on hyperoxia-exposed type II alveolar epithelial cells isolated from premature rat lungs in vitro].
    Chang LW; Zhu HP; Li WB; Liu HC; Zhang QS; Chen HB
    Zhonghua Er Ke Za Zhi; 2005 Feb; 43(2):118-23. PubMed ID: 15833168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of hydrocortisone therapy on severe leaky lung syndrome in ventilated preterm infants.
    Mizobuchi M; Iwatani S; Sakai H; Yoshimoto S; Nakao H
    Pediatr Int; 2012 Oct; 54(5):639-45. PubMed ID: 22463057
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Downregulatory cytokines in tracheobronchial aspirate fluid from infants with chronic lung disease of prematurity.
    Jónsson B; Li YH; Noack G; Brauner A; Tullus K
    Acta Paediatr; 2000 Nov; 89(11):1375-80. PubMed ID: 11106053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fibroblast mitogenic activity of lung lavage fluid from infants with chronic lung disease of prematurity.
    Currie AE; Kelly M; Vyas JR; Pandya H; Field D; Kotecha S
    Arch Dis Child Fetal Neonatal Ed; 2002 May; 86(3):F193-7. PubMed ID: 11978752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decreased use of postnatal corticosteroids in extremely preterm infants without increasing chronic lung disease.
    Seth R; Gray PH; Tudehope DI
    Neonatology; 2009; 95(2):172-8. PubMed ID: 18776732
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of dexamethasone on respirator-dependent very-low-birth-weight infants is best predicted by chest X-ray.
    Schrod L; Neuhaus T; Horwitz AE; Speer CP
    Pediatr Radiol; 2001 May; 31(5):332-8. PubMed ID: 11373920
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant human erythropoietin reduces epithelial cell apoptosis and attenuates bleomycin-induced pneumonitis in mice.
    Yoshimi M; Maeyama T; Yamada M; Hamada N; Fukumoto J; Kawaguchi T; Kuwano K; Nakanishi Y
    Respirology; 2008 Sep; 13(5):639-45. PubMed ID: 18713087
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hydrocortisone and long-term outcomes in very-low-birthweight infants.
    Yamasaki C; Uchiyama A; Nakanishi H; Masumoto K; Aoyagi H; Washio Y; Totsu S; Imai K; Kusuda S
    Pediatr Int; 2012 Aug; 54(4):465-70. PubMed ID: 22375549
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dexamethasone treatment does not inhibit fibroproliferation in chronic lung disease of prematurity.
    Dik WA; Versnel MA; Naber BA; Janssen DJ; van Kaam AH; Zimmermann LJ
    Eur Respir J; 2003 May; 21(5):842-7. PubMed ID: 12765431
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acinar arterial changes with chronic lung disease of prematurity in the surfactant era.
    Thibeault DW; Truog WE; Ekekezie II
    Pediatr Pulmonol; 2003 Dec; 36(6):482-9. PubMed ID: 14618639
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dexamethasone treatment of infants at risk for chronic lung disease: surfactant components and inflammatory parameters in airway specimens.
    Kari MA; Raivio KO; Venge P; Hallman M
    Pediatr Res; 1994 Sep; 36(3):387-93. PubMed ID: 7808837
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Randomized multi-center trial of the administration of erythropoietin in anemia of prematurity].
    Javier Manchón G; Natal Pujol A; Coroleu Lletget W; Zuasnábar Cotro A; Badía Barnusell J; Juncá Piera J; Bel Comós J; Sábado Alvarez C; Prats Viñas J
    An Esp Pediatr; 1997 Jun; 46(6):587-92. PubMed ID: 9297428
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of dexamethasone on tracheobronchial aspirate fluid cytology and pulmonary mechanics in preterm infants.
    Vento G; Matassa PG; Zecca E; Tortorolo L; Martelli M; De Carolis MP; Maggio L; Zini G; D'Onofrio G; Valentini S; Romagnoli C
    Pharmacology; 2004 Jul; 71(3):113-9. PubMed ID: 15161992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated platelet-derived growth factor-BB concentrations in premature neonates who develop chronic lung disease.
    Adcock KG; Martin J; Loggins J; Kruger TE; Baier RJ
    BMC Pediatr; 2004 Jun; 4():10. PubMed ID: 15198807
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Possible role of uric acid as an antioxidant in premature infants.
    Schrod L; Neuhaus T; Speer CP; Girschick H
    Biol Neonate; 1997; 72(2):102-11. PubMed ID: 9267676
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.